Alzheimer’s Disease Treatment

Regenerative therapies for Alzheimer’s disease: a continuum of care in neurodegeneration

At AMS Asia, we help individuals and families explore regenerative strategies for Alzheimer’s disease—an advanced, multifactorial neurodegenerative disorder that affects cognition, memory, and quality of life. Building on the same principles used in our Parkinson’s care pathways, we extend our support to Alzheimer’s patients through precision diagnostics, regenerative protocols, and integrative planning with leading institutions across Southeast Asia.

Alzheimer’s disease is marked by progressive neuronal loss, inflammation, and impaired cellular function. Conventional pharmaceutical treatments may temporarily ease symptoms, but they do not alter the underlying disease process. Our coordinated programs are designed to go further—addressing the root biological imbalances that contribute to cognitive decline.

Alzheimer’s as a multisystem brain disease

Alzheimer’s disease is more than just the presence of amyloid plaques or tau tangles. It involves multiple interconnected systems, including immune regulation, metabolism, vascular function, and cellular signaling. The condition is often characterized by:

• Chronic inflammation triggered by overactive microglia

• Mitochondrial dysfunction and disrupted cellular energy production

• Oxidative stress causing DNA damage and synaptic injury

• Compromised blood-brain barrier integrity

• Hormonal and metabolic imbalances, including cortisol and insulin dysregulation

To treat Alzheimer’s effectively, these systemic disruptions must be addressed alongside cognitive symptoms.

Regenerative cellular therapies: a precision-based strategy

AMS Asia supports access to innovative cell-based and cell-free therapies that are being integrated into Alzheimer’s care through clinical protocols across Southeast Asia. These therapies aim to protect, repair, and rewire the brain's healing capacity.
 

Mesenchymal Stem Cell (MSC) Therapy

MSCs offer a multi-pronged strategy for managing early to moderate Alzheimer’s disease. Their ability to modulate inflammation, promote regeneration, and restore cellular communication makes them an advanced tool in neurodegenerative care.

Key mechanisms include:

• Downregulation of inflammatory markers such as IL-6, TNF-α, and IL-1β

• Secretion of neurotrophic factors like BDNF, NGF, and VEGF that support neuron survival

• Restoration of mitochondrial integrity and ATP production

• Regulation of microglial and astrocyte activity to preserve synaptic function

• Enhancement of blood-brain barrier function and cortical tissue protection

Multiple studies, including one using intrathecal umbilical cord-derived MSCs, have reported cognitive improvements with good safety profiles. Repeat dosing has been well tolerated in clinical trials. [Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8426054/]
 

Exosome Therapy

Exosomes are nanoscale vesicles derived from MSCs, offering a cell-free therapeutic option with remarkable precision and safety. They carry molecular instructions that influence gene expression, reduce inflammation, and promote neuroregeneration.

Clinical advantages include:

• Ability to cross the blood-brain barrier with ease

• Reduction in tau phosphorylation and amyloid precursor protein misregulation

• Modulation of oxidative and inflammatory signaling in both neurons and glial cells

• Enhancement of synaptic plasticity and long-term cognitive function

Exosome therapy is particularly valuable for early-stage Alzheimer’s patients and can be used as a maintenance strategy due to its low immunogenic profile and non-invasive delivery.

Precision diagnostics, whole-system optimization

Each Alzheimer's care plan begins with comprehensive testing to identify the biological drivers of disease progression. AMS Asia coordinates advanced diagnostics through our partner clinics, ensuring that every therapeutic decision is based on real data.

Diagnostics may include:

• Neuroinflammatory marker panels (IL-6, CRP, TNF-α)

• Mitochondrial function and oxidative stress testing

• Genetic and epigenetic profiling, including ApoE status

• Hormonal evaluations for thyroid, adrenal, and sex hormones

• Gut-brain axis analysis, including microbiome and permeability tests

• Cognitive testing (MMSE, MoCA, neuropsychological assessments)

• Brain imaging when clinically appropriate

These insights enable highly personalized therapy plans aligned with each patient’s condition, goals, and stage of progression.

Adjunctive interventions, lifestyle integration

In addition to regenerative therapies, AMS Asia helps patients access a range of supportive interventions that reinforce neurological function and improve long-term outcomes.

These may include:

• IV nutrient infusions with NAD+, glutathione, CoQ10, and phosphatidylcholine

• Peptide therapies to support synaptic regeneration and neuroplasticity

• Bioidentical hormone optimization to enhance cerebral circulation and endocrine function

• Targeted detoxification protocols for heavy metal and environmental toxin clearance

• Nutritional and lifestyle coaching, including cognitive stimulation and sleep optimization

These interventions are combined based on diagnostic results and contribute to a truly integrative model of care that goes beyond managing decline—focusing instead on restoring quality of life.

Bridging Parkinson’s and Alzheimer’s: a shared neurodegenerative pathway

Alzheimer’s and Parkinson’s disease share many overlapping biological disruptions, including oxidative stress, chronic inflammation, mitochondrial dysfunction, and glial activation. At AMS Asia, we help patients benefit from a unified regenerative model that addresses both conditions through a shared framework of cellular repair and systemic optimization.

This allows for a seamless continuum of care, especially for individuals experiencing early cognitive symptoms alongside motor dysfunction or those with family histories of multiple neurodegenerative conditions.

Start the Journey Toward Cognitive Healing

If you or your loved one is living with Alzheimer’s or early cognitive decline, you do not have to settle for outdated treatment models. With the right strategy and regenerative support, a brighter path is possible.

Contact AMS Asia today to learn how we can help design a care plan that is personalized, data-driven, and focused on restoring what matters most—memory, clarity, and quality of life.